Objectives ANTXR2 variants have been associated with ankylosing spondylitis (AS) in two previous genome-wide association studies (GWAS) (p∼9×10−8). However, a genome-wide significant association (p<5×10−8) was not observed. We conducted a more comprehensive analysis of ANTXR2 in an independent UK sample to confirm and refine this association.
Methods A replication study was carried out with 2978 cases and 8365 controls. Then, these were combined with non-overlapping samples from the two previous GWAS in a meta-analysis. Human leukocyte antigen (HLA)-B27 stratification was also performed to test for ANTXR2-HLA-B27 interaction.
Results Out of nine single nucleotide polymorphisms (SNP) in the study, five SNPs were nominally associated (p<0.05) with AS in the replication dataset. In the meta-analysis, eight SNPs showed evidence of association, the strongest being with rs12504282 (OR=0.88, p=6.7×10−9). Seven of these SNPs showed evidence for association in the HLA-B27-positive subgroup, but none was associated with HLA-B27-negative AS. However, no statistically significant interaction was detected between HLA-B27 and ANTXR2 variants.
Conclusions ANTXR2 variants are clearly associated with AS. The top SNPs from two previous GWAS (rs4333130 and rs4389526) and this study (rs12504282) are in strong linkage disequilibrium (r2≥0.76). All are located near a putative regulatory region. Further studies are required to clarify the role played by these ANTXR2 variants in AS.
- Ankylosing Spondylitis
- Gene Polymorphism
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
The genetic association between ankylosing spondylitis (AS) and human leukocyte antigen (HLA)-B27 was first established 40 years ago. Subsequently, it has become clear that AS is a polygenic disease with over 40 variants at 28 loci involved.1 These include anthrax toxin receptor 2 (ANTXR2), also known as capillary morphogenesis gene 2 (CMG2) to take account of its functions in basement membrane matrix assembly, angiogenesis and embryonic development.2 Rare ANTXR2 mutations cause the recessive Mendelian conditions juvenile hyaline fibromatosis and infantile systemic hyalinosis,3 ,4 while common upstream variants show suggestive association with myopia.5 ANTXR2 has no obvious role in AS, but it contains two single nucleotide polymorphisms (SNP), rs4333130 and rs4389526, which are in strong linkage disequilibrium (LD) in Europeans,6 ,7 that have shown suggestive association with AS in two previous genome-wide association studies (GWAS). In 2010, the Triple A Australo-Anglo-American Spondyloarthritis Consortium (TASC) reported association with the intronic SNP, rs4333130 (p=9.3×10−8)7; and in 2011, the Wellcome Trust Case Control Consortium 2 (WTCCC2) showed an association with rs4389526 (meta-analysis p=9.4×10−8).6 In neither study did the evidence for association reach the threshold for genome-wide significance (p<5×10−8). Subsequently, two smaller Chinese studies failed to show association with ANTXR2.8 ,9 Unfortunately, neither of the two strongly associated ANTXR2 SNPs was included in the recent Immunochip study designed to replicate and refine suspected genetic associations with AS.1 Consequently, we sought to clarify the potential association through a more comprehensive analysis of ANTXR2 in another independent UK sample prior to starting more detailed analysis of this region.
Materials and methods
Patients, controls and statistics
The study was approved by the National Research Ethics Service, Cambridgeshire 4 Research Ethics Committee, UK (MREC project number 98/5/23). We studied 2978 AS cases fulfilling the 1984 modified New York Criteria10 who were not in the previous TASC 20107 or WTCCC2 analyses.6 Cases were genotyped on nine SNPs within ANTXR2 that had previously shown evidence of association with AS (p<0.05) in the TASC 2010 study.7 SNPs were genotyped using KASP technology (competitive allele-specific polymerase chain reaction amplification) by LGC Genomics (Hoddesdon, UK). Genotyping assays were validated on KASP panels, and cluster plots were checked for clearly separated genotype clusters.
Cases were compared to 8365 children from the Avon Longitudinal Study of Parents And Children who had previously been genotyped on the Illumina 550K platform (rs4234848, rs11098965, rs4444771, rs10000471, rs4333130, rs6839672) and then imputed to HapMap 2 as previously described (rs12504282, rs6534639 and rs4640621; imputation quality R2≥0.98).11 ,12 Please note that the study website contains details of all the data that is available through a fully searchable data dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/).
Control allele frequencies were checked for Hardy–Weinberg equilibrium (all p>0.05). Allele frequencies between cases and controls were compared by logistic regression analysis. Where SNPs were imputed, ‘best guess’ genotypes were used in the calculation (all R2≥0.98). All statistical analyses were carried out using using the software programme PLINK (http://pngu.mgh.harvard.edu/purcell/plink).13 Expected power of the study was based on the ORs from the TASC 2010 GWAS discovery sample.7 We estimate that our study had 98% statistical power to detect an association corresponding to an allelic OR of 0.82, with a minor allele frequency of 0.31, an α of 0.05 (two-sided), and a disease prevalence of 4/1000, assuming an additive model for disease risk (http://www.dartmouth.edu/~eugened/power-samplesize.php).
Cases and controls were stratified by HLA-B27 status, and tested for association using logistic regression analysis. HLA-B27 status of cases and controls was determined using the rs4349859 marker, which tags HLA-B27 in Europeans with very high sensitivity and specificity.6
ORs from the TASC 2010 (1236 cases, 3979 controls), WTCCC2 2011 (1787 cases, 5162 controls) and this study were combined in an inverse variance meta-analysis assuming a fixed effects model. Combinability of the studies was determined using Cochran's Q test (p>0.05), and the inconsistency measure (I2) was used to estimate the amount of heterogeneity across the studies in the meta-analysis. For TASC, the analysis included correction for four principal components due to the different ethnicities in that study.7 Genome-wide significance level (p<5×10−8) was used for declaring statistically significant genetic association. Meta-analysis conditioning on rs12504282 was also performed to detect secondary signals at the locus. Forest plots were produced using the metafor package in R.
ANTXR2-HLA-B27 interaction analysis
Logistic regression analyses were performed in each cohort using the model (logOdds=B0+HLA-B27(dominant)+ANTXR2(additive)+ANTXR2xHLA-B27). The logORs and SEs for the interaction terms were combined in an inverse variance meta-analysis to test for the presence of an ANTXR2-HLA-B27 interaction.
LocusZoom was used to display a regional association plot showing the pairwise LD between the top SNP and the other SNPs in the meta-analysis (1000 Genomes March 2012 European panel).14 The University of California, Santa Cruz (UCSC) genome browser (http://genome-euro.ucsc.edu/index.html) was used to interrogate the Encyclopaedia of DNA elements (ENCODE) data for regions of interest containing the associated SNPs.15 ,16 Public eQTL databases were used to determine possible effects of SNPs in the ANTXR2 region on gene expression (eQTL databases: http://www.sph.umich.edu/csg/liang/imputation/17 and http://www.hsph.harvard.edu/liming-liang/software/eqtl/; GTEx: http://www.gtexportal.org; Genevar18: http://www.sanger.ac.uk/resources/software/genevar/).
Five SNPs showed nominal evidence of association (p<0.05) with AS in the expected direction (table 1A). Four of these SNPs were also nominally associated with AS in the HLA-B27-positive subgroup analysis (table 1B), whereas only one of these showed nominal evidence of association in HLA-B27-negative AS (table 1C). There appeared to be a difference in the point estimates of the ORs between HLA-B27-positive and negative individuals (with HLA-B27-positive individuals showing stronger association for most SNPs) although the CIs around the estimates were wide.
In the meta-analysis, three SNPs showed strong evidence of association with AS (p<5×10−8), while five SNPs exhibited suggestive associations (4.5×10−6≤p≤0.0007; table 2A). Forest plots revealed that the direction and strength of the association was consistent across most SNPs (figure 1). Conditional analysis indicated no associations independent of rs12504282 (all p>0.1). Seven of the SNPs showed nominal evidence for association in the HLA-B27-positive AS subgroup (table 2B), but none was associated with HLA-B27-negative AS (p>0.05; table 2C). However, no statistically significant interaction was detected between HLA-B27 and ANTXR2 variants (p>0.05).
This study convincingly replicated the association between ANTXR2 variants and AS in an independent UK sample with three variants reaching genome-wide significance level in the meta-analysis. In the replication study, the strongest association was with rs12504282 (p=0.0001, OR=0.89, 95% CI 0.84 to 0.94), but there is a high degree of LD across this locus and the five SNPs showing significant association (table 1A) are distributed across the locus (figure 2). In the meta-analysis, eight SNPs showed evidence of association, three SNPs reaching genome-wide significance; rs12504282 again showed the strongest association (p=6.7×10−9, OR=0.88). Forest plots show that direction and magnitude of association across the studies in the meta-analysis are in agreement with overlapping CIs (figure 1).
The strength of evidence for association appeared to be stronger in HLA-B27-positive patients compared with the HLA-B27 negatives. None of the seven SNPs, which showed nominal evidence of association with HLA-B27-positive AS showed nominal association with HLA-B27-negative disease, including the top SNP rs12504282 (table 1B, C). However, failure to detect nominal association with ANTXR2 in HLA-B27-negative AS probably reflects reduced statistical power rather than a genuine epistatic interaction. Consistent with this interpretation, the ANTXR2-HLA-B27 interaction analysis statistically testing for an epistatic effect revealed no significant findings. By contrast, the well-established epistatic genetic effect between HLA-B27 and ERAP1 in AS6 can be explained by the functional synergy between ERAP1 and HLA class I molecules in antigen processing and presentation.19 It is much less easy to explain a putative genetic interaction with ANTXR2 where there is no known functional interplay with HLA-B27 at the molecular level.
Biological explanations for the consistent associations of ANTXR2 variants with AS have not yet been forthcoming. The top SNPs from three different studies,6 ,7 including this one, are in close proximity and strongly correlated (rs4333130, rs4389526 and rs12504282; r2>0.76). Furthermore, these SNPs are near a putative transcription factor-binding region, and may therefore affect the expression level of ANTXR2 or another gene (figure 2). ANTXR2 is widely expressed in many tissues. Interrogation of expressed quantitative trait loci (eQTL) databases revealed SNP rs4690110 with a strong cis-eQTL effect on ANTXR2 expression in adipose tissue (p=7.6×10−9, β=0.14),18 but rs4690110 is weakly correlated with the top SNP rs12504282 (r2=0.27), and adipose tissue is not thought to be directly relevant to AS. Therefore, it is unlikely that this cis-eQTL effect explains the observed AS association in this region. However, the specific effects of the associated ANTXR2 SNPs may differ in tissues relevant to AS. Of interest, rs4333130 and rs12504282 have trans-eQTL effects on the expression of NSMAF on chromosome 8 (allele A, β=−0.27, p=0.00025) and GPR89A on chromosome 1 (allele T, β=−0.25, p=0.00088), respectively, in lymphoblastoid cell lines.17 NSMAF encodes a WD-repeat protein potentially playing a role in regulating tumour necrosis factor-induced cellular responses, such as inflammation. GPR89A encodes G protein-coupled receptor 89A involved in Golgi apparatus acidification possibly modulating its functions.20 Substantially more work will be required before the nature of this tantalising genetic association with AS can be explained at a functional level.
We are extremely grateful to all the families who took part in the Avon Longitudinal Study of Parents And Children (ALSPAC), the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. This publication is the work of the authors and DME will serve as guarantor for the contents of this paper. The authors are also grateful for the support of the National Ankylosing Spondylitis Society UK and the NIHR Thames Valley CLRN for their roles in facilitating the recruitment of cases.
Handling editor Tore K Kvien
DME and BPW are joint senior authors.
Contributors TK performed the statistical analyses and wrote the manuscript. SMK and JJP contributed to study design and HLA genotyping. LHA prepared and HLA genotyped samples. MAB contributed to critical revision of the manuscript. BPW and DME contributed to subject recruitment/data collection and supervised the study. All authors participated in manuscript drafting and final manuscript review.
Funding The UK Medical Research Council, the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. TK was funded by the National Ankylosing Spondylitis Society. SK and JJP were funded by the NIHR Oxford Comprehensive Biomedical Research Centre (A91202) and by an unrestricted educational grant from Abbvie. This study was funded in part by grants from Arthritis Research UK (19536 and 18797).
Competing interests None.
Ethics approval National Research Ethics Service, Cambridgeshire 4 Research Ethics Committee, UK (MREC project number 98/5/23); ALSPAC Ethics and Law Committee and Local Research Ethics Committees.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.